Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-113908
Filing Date
2024-11-04
Accepted
2024-11-04 16:16:21
Documents
1
Group Members
INVIK S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427110d1_sc13ga.htm SC 13G/A 80651
  Complete submission text file 0001104659-24-113908.txt   82333
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Subject) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92498 | Film No.: 241423777
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address SKEPPSBRON 18 STOCKHOLM V7 SE-10313
Business Address SKEPPSBRON 18 STOCKHOLM V7 SE-10313 46 8 526 000 00
Kinnevik AB (publ) (Filed by) CIK: 0001766574 (see all company filings)

EIN.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G/A